Method and device for administering dexmedetomidine transdermally
US5217718A · kind A · utility
67Cited by
4References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 17, 1991 |
| Grant date | Jun 8, 1993 |
| Priority date | — |
| Expiry date | Sep 17, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/415
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Transdermal administration of dexmedetomidine, the dextrorotatory isomer of medetomidine, is described. The method involves sedating a patient by administering dexmedetomidine to a predetermined area of skin at an administration rate and for a time period effective to achieve the desired level of sedation. A therapeutic system for transdermally administering the drug is also provided. The therapeutic system is in the form of a skin patch which is a laminated composite of a backing layer, an optional anchor adhesive layer, a contact adhesive layer, and one or more additional layers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.